儿童幽门螺杆菌感染治疗现状及进展
Current Status and Progress in the Treatment of Helicobacter pylori Infection in Children
DOI: 10.12677/acm.2024.1451480, PDF,   
作者: 樊 芬:延安大学医学院,陕西 延安;马 科:延安大学附属医院儿科,陕西 延安
关键词: 幽门螺杆菌儿童感染治疗药物耐药性个体化治疗Helicobacter pylori Children Infection Treatment Antibiotic Resistance Individualized Treatment
摘要: 随着幽门螺杆菌(Helicobacter pylori, H. pylori)在儿童中感染率的持续关注,其治疗方法和感染后果引起了广泛的研究兴趣。本文综述分析了关于儿童H. pylori感染治疗及相关健康影响的研究文献。研究集中在H. pylori与儿童健康关联性,全球流行病学特征,与其他疾病风险的关联,以及菌群感染的症状和治疗响应上。本文将探讨根除H. pylori对改善功能性消化不良症状的重要性,以及抗生素耐药性等问题。综合现有研究表明,序贯疗法和三联疗法是常用的治疗胃溃疡并发的方案,而抗生素靶基因突变与药物耐药性的关系仍在研究之中。总体看来,研究强调了针对不同地区、不同亚型H. pylori感染的个体化治疗策略的重要性。未来研究需关注治疗方案的优化以及耐药性的长期监测。
Abstract: With continued concern about the rate of infection of Helicobacter pylori (H. pylori) in children, its treatment and the consequences of infection have attracted extensive research interest. This paper reviews the literature on the treatment of H. pylori infection in children and its related health effects. Studies have focused on H. pylori’s association with child health, global epidemiological characteristics, associations with risk of other diseases, and symptoms and treatment responses to bacterial infection. This article will explore the importance of eradicating H. pylori in improving symptoms of functional dyspepsia, as well as issues such as antibiotic resistance. Summary of existing studies shows that sequential therapy and triple therapy are commonly used to treat gastric ulcer complications, but the relationship between antibiotic target gene mutation and drug resistance is still under study. Overall, the study highlights the importance of individualized treatment strategies for different regions and subtypes of H. pylori infection. Future studies need to focus on the optimization of treatment protocols and long-term monitoring of drug resistance.
文章引用:樊芬, 马科. 儿童幽门螺杆菌感染治疗现状及进展[J]. 临床医学进展, 2024, 14(5): 702-707. https://doi.org/10.12677/acm.2024.1451480

参考文献

[1] Cam, S. (2014) Risk of Gastric Cancer in Children with Helicobacter pylori Infection. Asian Pacific Journal of Cancer Prevention: APJCP, 15, 9905-9908. [Google Scholar] [CrossRef
[2] Camilo, V., Sugiyama, T. and Touati, E. (2017) Pathogenesis of Helicobacter pylori Infection. Helicobacter, 22. [Google Scholar] [CrossRef] [PubMed]
[3] Wei, S.C., Dang, Y.N. and Peng, L. (2020) Association between Helicobacter pylori Infection and Delayed Growth in Children: A Meta-Analysis. Experimental and Therapeutic Medicine, 19, 3814-3828.
[4] Elsaadany, E., Amin, S., Abdel-Hafez, M., El Amrousy, D., Kasem, S., Abd Elaziz, D. and Shawky, D. (2022) Study of Serum Ferritin, Zinc, and Copper Levels in Children with Helicobacter pylori Gastritis and the Effect of the Treatment. Journal of Pediatric Gastroenterology and Nutrition, 75, e88-e93. [Google Scholar] [CrossRef
[5] 杨静怡. 不同亚型幽门螺旋杆菌感染与功能性消化不良症状的关系研究[D]: [硕士学位论文]. 十堰: 湖北医药学院, 2020.
[6] Seo, J.H., Bortolin, K. and Jones, N.L. (2020) Review: Helicobacter pylori Infection in Children. Helicobacter, 25, e12742. [Google Scholar] [CrossRef] [PubMed]
[7] 庄建新. 幽门螺杆菌感染并发胃溃疡的临床治疗效果研究[J]. 母婴世界, 2020(28): 69.
[8] Xu, C., Wu, Y. and Xu, S. (2022) Association between Helicobacter pylori Infection and Growth Outcomes in Children: A Meta-Analysis. Helicobacter, 27, e12861. [Google Scholar] [CrossRef] [PubMed]
[9] Chen, Y., Liu, Q.Y. and Hu, F.L. (2020) Identifying the Best Regimen for Primary Eradication of Helicobacter pylori: Analysis of 240 Cases. Microbiologyopen, 9, e1120. [Google Scholar] [CrossRef] [PubMed]
[10] Manfredi, M., Gaiani, F., Kayali, S., Bizzarri, B., Iuliano, S., Minelli, R., Leandro, G., Di Mario, F. and De’Angelis, G.L. (2018) How and When Investigating and Treating Helicobacter pylori Infection in Children. Acta Biomedica Atenei Parmensis, 89, 65-71.
[11] Zhang, Y.Y., Wen, Y. and Xiao, Q.L. (2020) Mutations in the Antibiotic Target Genes Related to Clarithromycin, Metronidazole and Levofloxacin Resistance in Helicobacter pylori Strains from Children in China. Infection and Drug Resistance, 13, 311-322. [Google Scholar] [CrossRef
[12] Roma, E. and Miele, E. (2015) Helicobacter pylori Infection in Pediatrics. Helicobacter, 20, 47-53. [Google Scholar] [CrossRef] [PubMed]
[13] 张声生. 治疗幽门螺杆菌中医分三型[J]. 农村百事通, 2020(15): 57.
[14] Sabbi, T., De Angelis, P. and Dall’Oglio, L. (2008) Helicobacter pylori Infection in Children: Management and Pharmacotherapy. Expert Opinion on Pharmacotherapy, 9, 577-585. [Google Scholar] [CrossRef] [PubMed]
[15] Daugule, I. and Rowland, M. (2008) Helicobacter pylori Infection in Children. Helicobacter, 13, 41-46. [Google Scholar] [CrossRef] [PubMed]
[16] Kalach, N., Bontems, P. and Raymond, J. (2017) Helicobacter pylori Infection in Children. Helicobacter, 22. [Google Scholar] [CrossRef] [PubMed]
[17] Kotilea, K., Kalach, N., Homan, M. and Bontems, P. (2018) Helicobacter pylori Infection in Pediatric Patients: Update on Diagnosis and Eradication Strategies. Paediatric Drugs, 20, 337-351. [Google Scholar] [CrossRef] [PubMed]
[18] Dror, G. and Muhsen, K. (2016) Helicobacter pylori Infection and Children’s Growth: An Overview. Journal of Pediatric Gastroenterology and Nutrition, 62, e48-e59. [Google Scholar] [CrossRef
[19] Mišak, Z., Hojsak, I. and Homan, M. (2019) Review: Helicobacter pylori in Pediatrics. Helicobacter, 24, e12639. [Google Scholar] [CrossRef] [PubMed]
[20] Gilger, M.A. (2000) Treatment of Helicobacter pylori Infection in Children. Current Pharmaceutical Design, 6, 1531-1536. [Google Scholar] [CrossRef] [PubMed]
[21] 贾真, 袁雪晶. 儿童幽门螺杆菌感染治疗进展[J]. 儿科药学杂志, 2019, 25(6): 58-61. [Google Scholar] [CrossRef
[22] 刘洪英. 幽门螺杆菌感染的治疗现状及进展[J]. 中国处方药, 2018, 16(4): 15-17.
[23] 欧廷宏, 向平, 周卫华. 幽门螺杆菌感染现状及临床治疗研究进展[J]. 中国当代医药, 2018, 25(5): 28-31.
[24] 黄艳, 詹学. 儿童幽门螺杆菌感染现状及其相关性疾病的研究进展[J]. 儿科药学杂志, 2017, 23(2): 53-57. [Google Scholar] [CrossRef
[25] 郝静, 闫慧敏. 儿童幽门螺杆菌感染研究现状及中西医治疗进展[J]. 北京中医药, 2013, 32(1): 68-71. [Google Scholar] [CrossRef
[26] 陈洁. 儿童幽门螺杆菌感染的诊断和治疗进展[J]. 临床儿科杂志, 2005(10): 9-11.